Migergot
NDC Package 60809-166-12
Package Information
Migergot is this combination medication is used to treat or prevent a certain type of headache (vascular headaches such as migraine headaches and cluster headaches). Marketed by Horizon Pharma Inc., this product is identified by NDC 60809-166 and is authorized under FDA application ANDA086557.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 60809 - Horizon Pharma Inc.
- 60809-166 - Migergot
- 60809-166-12 - 12 SUPPOSITORY in 1 CARTON
- 60809-166 - Migergot
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60809-166-12 identifies a specific commercial package of 12 suppository in 1 carton of Migergot, labeled by Horizon Pharma Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 12 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Horizon Pharma Inc. on October 01, 2014. The current certification is valid through November 30, 2017.
What are the primary indications for this medication?
This combination medication is used to treat or prevent a certain type of headache (vascular headaches such as migraine headaches and cluster headaches). Ergotamine helps narrow widened blood vessels in the head, which reduces the throbbing effects of vascular headaches. Caffeine increases the effects of ergotamine by also narrowing the widened blood vessels in the head. The suppository form is used when medications cannot be taken by mouth (for example, due to nausea and vomiting).
How is this Horizon Pharma Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60809016612. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 12 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.